Mark I Johnson Author
Editorial Open Access
Author(s): Mark I Johnson and Helen Radford
CYP2D6 Polymorphisms and Response to Codeine and Tramadol
The science of how an individual’s genotype affects the body’s response to drugs, termed pharmacogenomics, began in the late 1950’s. Since then the promise that medicines could be tailored to the individual instead of the one-size-fits-all approach has been heralded as the future of medicine [1-3]. However, pharmacogenomics has made very little impact on the practice of pain management at the point of care and cli... view moreĀ»